91 related articles for article (PubMed ID: 23688984)
21. The genomic landscape of epithelioid sarcoma cell lines and tumours.
Jamshidi F; Bashashati A; Shumansky K; Dickson B; Gokgoz N; Wunder JS; Andrulis IL; Lazar AJ; Shah SP; Huntsman DG; Nielsen TO
J Pathol; 2016 Jan; 238(1):63-73. PubMed ID: 26365879
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors.
Wöhrle S; Weiss A; Ito M; Kauffmann A; Murakami M; Jagani Z; Thuery A; Bauer-Probst B; Reimann F; Stamm C; Pornon A; Romanet V; Guagnano V; Brümmendorf T; Sellers WR; Hofmann F; Roberts CW; Graus Porta D
PLoS One; 2013; 8(10):e77652. PubMed ID: 24204904
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of expression of the chromatin remodeling gene, SNF2L, selectively leads to DNA damage, growth inhibition, and cancer cell death.
Ye Y; Xiao Y; Wang W; Wang Q; Yearsley K; Wani AA; Yan Q; Gao JX; Shetuni BS; Barsky SH
Mol Cancer Res; 2009 Dec; 7(12):1984-99. PubMed ID: 19996304
[TBL] [Abstract][Full Text] [Related]
24. Chromatin remodeling: from transcription to cancer.
Yaniv M
Cancer Genet; 2014 Sep; 207(9):352-7. PubMed ID: 24825771
[TBL] [Abstract][Full Text] [Related]
25. Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability.
Imbalzano AN; Jones SN
Cancer Cell; 2005 Apr; 7(4):294-5. PubMed ID: 15837618
[TBL] [Abstract][Full Text] [Related]
26. Complementation analyses suggest species-specific functions of the SNF5 homology domain.
Bonazzi V; Medjkane S; Quignon F; Delattre O
Biochem Biophys Res Commun; 2005 Oct; 336(2):634-8. PubMed ID: 16154112
[TBL] [Abstract][Full Text] [Related]
27. Cc.snf5, a gene encoding a putative component of the SWI/SNF chromatin remodeling complex, is essential for sexual development in the agaricomycete Coprinopsis cinerea.
Ando Y; Nakazawa T; Oka K; Nakahori K; Kamada T
Fungal Genet Biol; 2013 Jan; 50():82-9. PubMed ID: 23078835
[TBL] [Abstract][Full Text] [Related]
28. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.
Jagani Z; Mora-Blanco EL; Sansam CG; McKenna ES; Wilson B; Chen D; Klekota J; Tamayo P; Nguyen PT; Tolstorukov M; Park PJ; Cho YJ; Hsiao K; Buonamici S; Pomeroy SL; Mesirov JP; Ruffner H; Bouwmeester T; Luchansky SJ; Murtie J; Kelleher JF; Warmuth M; Sellers WR; Roberts CW; Dorsch M
Nat Med; 2010 Dec; 16(12):1429-33. PubMed ID: 21076395
[TBL] [Abstract][Full Text] [Related]
29. Absence of mutations on the SNF5 gene in hematological neoplasms with chromosome 22 abnormalities.
Mori N; Inoue K; Okada M; Motoji T
Acta Haematol; 2011; 126(2):69-75. PubMed ID: 21494030
[TBL] [Abstract][Full Text] [Related]
30. Essential roles of Snf5p in Snf-Swi chromatin remodeling in vivo.
Geng F; Cao Y; Laurent BC
Mol Cell Biol; 2001 Jul; 21(13):4311-20. PubMed ID: 11390659
[TBL] [Abstract][Full Text] [Related]
31. Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.
Pottier N; Cheok MH; Yang W; Assem M; Tracey L; Obenauer JC; Panetta JC; Relling MV; Evans WE
Hum Mol Genet; 2007 Oct; 16(19):2261-71. PubMed ID: 17616514
[TBL] [Abstract][Full Text] [Related]
32. Functional interaction of the retinoblastoma and Ini1/Snf5 tumor suppressors in cell growth and pituitary tumorigenesis.
Guidi CJ; Mudhasani R; Hoover K; Koff A; Leav I; Imbalzano AN; Jones SN
Cancer Res; 2006 Aug; 66(16):8076-82. PubMed ID: 16912184
[TBL] [Abstract][Full Text] [Related]
33. SNF5 deficiency induces apoptosis resistance by repressing SATB1 expression in Sézary syndrome.
Li Y; Wang J; Yu M; Wang Y; Zhang H; Yin J; Li Z; Li T; Yan H; Li F; Wang X
Leuk Lymphoma; 2018 Oct; 59(10):2405-2413. PubMed ID: 29334836
[TBL] [Abstract][Full Text] [Related]
34. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression.
Klochendler-Yeivin A; Fiette L; Barra J; Muchardt C; Babinet C; Yaniv M
EMBO Rep; 2000 Dec; 1(6):500-6. PubMed ID: 11263494
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of early steps of HIV-1 replication by SNF5/Ini1.
Maroun M; Delelis O; Coadou G; Bader T; Ségéral E; Mbemba G; Petit C; Sonigo P; Rain JC; Mouscadet JF; Benarous R; Emiliani S
J Biol Chem; 2006 Aug; 281(32):22736-43. PubMed ID: 16772295
[TBL] [Abstract][Full Text] [Related]
36. The SWI/SNF complex--chromatin and cancer.
Roberts CW; Orkin SH
Nat Rev Cancer; 2004 Feb; 4(2):133-42. PubMed ID: 14964309
[No Abstract] [Full Text] [Related]
37. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice.
Roberts CW; Galusha SA; McMenamin ME; Fletcher CD; Orkin SH
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13796-800. PubMed ID: 11095756
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of MYC by the SMARCB1 tumor suppressor.
Weissmiller AM; Wang J; Lorey SL; Howard GC; Martinez E; Liu Q; Tansey WP
Nat Commun; 2019 May; 10(1):2014. PubMed ID: 31043611
[TBL] [Abstract][Full Text] [Related]
39. SMARCB1 deletion by a complex three-way chromosomal translocation in an extrarenal malignant rhabdoid tumor.
Bahrami A; Lee S; Caradine KD; Raimondi SC; Folpe AL
Cancer Genet; 2014 Sep; 207(9):437-40. PubMed ID: 25312828
[TBL] [Abstract][Full Text] [Related]
40. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1.
Caramel J; Quignon F; Delattre O
Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
